XML 14 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Number of shares of common stock
Common stock and additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Beginning Balance (in shares) at Dec. 31, 2021   558.3      
Balance as of beginning of period at Dec. 31, 2021 $ 6,700   $ 32,096 $ (24,600) $ (796)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income for basic and diluted EPS 1,476     1,476  
Other comprehensive loss, net of taxes 33       33
Dividends declared on common stock (1,034)     (1,034)  
Issuance of common stock in connection with the Company’s equity award programs (in shares)   0.5      
Issuance of common stock in connection with the Company’s equity award programs 18   18    
Stock-based compensation expense 78   78    
Tax impact related to employee stock-based compensation expense (45)   (45)    
Repurchases of common stock (in shares)   (24.6)      
Repurchases of common stock (6,310)   (900) (5,410)  
Ending Balance (in shares) at Mar. 31, 2022   534.2      
Balance as of end of period at Mar. 31, 2022 916   31,247 (29,568) (763)
Beginning Balance (in shares) at Dec. 31, 2021   558.3      
Balance as of beginning of period at Dec. 31, 2021 6,700   32,096 (24,600) (796)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income for basic and diluted EPS 4,936        
Ending Balance (in shares) at Sep. 30, 2022   533.5      
Balance as of end of period at Sep. 30, 2022 3,653   32,371 (28,066) (652)
Beginning Balance (in shares) at Mar. 31, 2022   534.2      
Balance as of beginning of period at Mar. 31, 2022 916   31,247 (29,568) (763)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income for basic and diluted EPS 1,317     1,317  
Other comprehensive loss, net of taxes 91       91
Issuance of common stock in connection with the Company’s equity award programs (in shares)   0.7      
Issuance of common stock in connection with the Company’s equity award programs 45   45    
Stock-based compensation expense 120   120    
Tax impact related to employee stock-based compensation expense (69)   (69)    
Other (1)     (1)  
Ending Balance (in shares) at Jun. 30, 2022   534.9      
Balance as of end of period at Jun. 30, 2022 2,419   31,343 (28,252) (672)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income for basic and diluted EPS 2,143     2,143  
Other comprehensive loss, net of taxes 20       20
Dividends declared on common stock (1,057)     (1,057)  
Issuance of common stock in connection with the Company’s equity award programs (in shares)   0.1      
Issuance of common stock in connection with the Company’s equity award programs 15   15    
Stock-based compensation expense 121   121    
Tax impact related to employee stock-based compensation expense (8)   (8)    
Repurchases of common stock (in shares)   (1.5)      
Repurchases of common stock 0   900 (900)  
Ending Balance (in shares) at Sep. 30, 2022   533.5      
Balance as of end of period at Sep. 30, 2022 $ 3,653   32,371 (28,066) (652)
Beginning Balance (in shares) at Dec. 31, 2022 534.0 534.0      
Balance as of beginning of period at Dec. 31, 2022 $ 3,661   32,514 (28,622) (231)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income for basic and diluted EPS 2,841     2,841  
Other comprehensive loss, net of taxes (37)       (37)
Dividends declared on common stock (1,138)     (1,138)  
Issuance of common stock in connection with the Company’s equity award programs (in shares)   0.3      
Issuance of common stock in connection with the Company’s equity award programs 11   11    
Stock-based compensation expense 47   47    
Tax impact related to employee stock-based compensation expense (37)   (37)    
Ending Balance (in shares) at Mar. 31, 2023   534.3      
Balance as of end of period at Mar. 31, 2023 $ 5,348   32,535 (26,919) (268)
Beginning Balance (in shares) at Dec. 31, 2022 534.0 534.0      
Balance as of beginning of period at Dec. 31, 2022 $ 3,661   32,514 (28,622) (231)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income for basic and diluted EPS $ 5,950        
Ending Balance (in shares) at Sep. 30, 2023 535.1 535.1      
Balance as of end of period at Sep. 30, 2023 $ 7,656   32,753 (24,971) (126)
Beginning Balance (in shares) at Mar. 31, 2023   534.3      
Balance as of beginning of period at Mar. 31, 2023 5,348   32,535 (26,919) (268)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income for basic and diluted EPS 1,379     1,379  
Other comprehensive loss, net of taxes (12)       (12)
Issuance of common stock in connection with the Company’s equity award programs (in shares)   0.6      
Issuance of common stock in connection with the Company’s equity award programs 16   16    
Stock-based compensation expense 119   119    
Tax impact related to employee stock-based compensation expense (69)   (69)    
Ending Balance (in shares) at Jun. 30, 2023   534.9      
Balance as of end of period at Jun. 30, 2023 6,781   32,601 (25,540) (280)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income for basic and diluted EPS 1,730     1,730  
Other comprehensive loss, net of taxes 154       154
Dividends declared on common stock (1,161)     (1,161)  
Issuance of common stock in connection with the Company’s equity award programs (in shares)   0.2      
Issuance of common stock in connection with the Company’s equity award programs 33   33    
Stock-based compensation expense 124   124    
Tax impact related to employee stock-based compensation expense $ (5)   (5)    
Ending Balance (in shares) at Sep. 30, 2023 535.1 535.1      
Balance as of end of period at Sep. 30, 2023 $ 7,656   $ 32,753 $ (24,971) $ (126)